Medication adherence and significant others' support of consumers with schizophrenia in Australia

Nursing and Health Sciences

Volumn 11, Issue 3, 2009, Pages 228-234

  Mccann, Terence V ^a   Lu, Sai ^a  

^a VICTORIA UNIVERSITY   (Australia)

Author keywords

Consumers; Medication adherence; Schizophrenia; Significant other support; Survey

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; AUSTRALIA; CHRONIC DISEASE; EXPLORATORY RESEARCH; FEMALE; HUMAN; HUMAN RELATION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; SCHIZOPHRENIA; SELF REPORT; SEX DIFFERENCE; SOCIAL SUPPORT; SPOUSE; MEDICATION COMPLIANCE; MENTAL HEALTH; MENTAL HEALTH SERVICE; NURSING; PATIENT SATISFACTION; PSYCHOMETRY;

ADULT; ANTIPSYCHOTIC AGENTS; AUSTRALIA; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MENTAL HEALTH; MENTAL HEALTH SERVICES; PATIENT SATISFACTION; PSYCHOMETRICS; SCHIZOPHRENIA; SOCIAL SUPPORT; SPOUSES; VICTORIA;

EID: 69249135907     PISSN: 14410745     EISSN: 14422018     Source Type: Journal    
DOI: 10.1111/j.1442-2018.2009.00440.x     Document Type: Article

References (38)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association, 2000.
2. Ammassari A, Trotta MP, Murri R et al. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. J. Acquir. Immune Defic. Syndr. 2002; 31 (Suppl. 3): 123-127.
3. Ayuso-Mateos JL, Pereda A, Dunn G et al. Predictors of compliance with psychological interventions offered in the community. Psychol. Med. 2007; 37: 717-725.
4. Buckley LA, Pettit TACL, Adams CE. Supportive therapy for schizophrenia. Cochrane Database Syst. Rev. 2007; 3: Art. no. CD004716.
5. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychotic illness. Acta Psychiatr. Scand. 2002; 106: 286-290.
6. Danion JM, Huron C, Vidailhet P, Berna F. Functional mechanisms of episodic memory impairment in schizophrenia. Can. J. Psychiatry 2007; 52: 693-701.
7. Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: Review of recent literature. J. Clin. Psychopharmacol. 2003; 23: 389-399.
8. Edwards L. Women and HIV/AIDS: Exploring the relationship between medication adherence and perceived social support among African American women ages 40-49. In: 15th International AIDS Conference Bangkok; 11-16 Jul 2004; Bangkok, Thailand. Bangkok: International AIDS Society, 2004.
9. Geckova A, van Dijk JP, Stewart R, Groothoff JW, Post D. Influence of social support on health among gender and socio-economic groups of adolescents. Eur. J. Public Health 2003; 13: 44-50.
10. Gilmer TP, Dolder CR, Lacro JP et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am. J. Psychiatry 2004; 161: 692-699.
11. Gottlieb H. Medication nonadherence: Finding solutions to a costly medical problem. Drug Bene. Trends 2000; 12: 57-62.
12. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions for enhancing medication adherence (review). Cochrane Database Syst. Review 2005; 4: Art. no. CD000011.
13. Kikkert MJ, Schene AH, Koeter MW et al. Medication adherence in schizophrenia: Exploring patients', carers' and professionals' views. Schizophr. Bull. 2006; 32: 786-794.
14. Kozuki Y, Schepp KG. Adherence and nonadherence to antipsychotic medications. Issues Ment. Health Nurs. 2005; 26: 379-396.
15. Kyngas H, Rissanen M. Support as a crucial predictor of good compliance of adolescents with a chronic disease. J. Clin. Nurs. 2001; 10: 767-774.
16. Kyngas HA, Kroll T, Duffy ME. Compliance in adolescents with chronic diseases: A review. J. Adolesc. Health 2000; 26: 379-388.
17. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry 2002; 63: 892-909.
18. Lanouette NM, Folsom DP, Sciolla A, Jeste DV. Psychotropic medication nonadherence among United States Latinos: A comprehensive literature review. Psychiatr. Serv. 2009; 60: 157-174.
19. McCann TV, Clark E. Attitudes of patients towards mental health nurse prescribing of antipsychotic agents. Int. J. Nurs. Prac. 2008; 14: 115-121.
20. McCann TV, Boardman G, Clark E, Lu S. Risk profiles for non-adherence to antipsychotic medications. J. Psychiatr. Ment. Health Nurs. 2008; 15: 622-629.
21. McIntosh AM, Conlon L, Lawrie SM, Stanfield AC. Compliance therapy for schizophrenia (review). Cochrane Database Syst. Rev. 2006; 3: Art. no. CD003442.
22. Morken G, Grawe RW, Widen JH. Effects of integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia. J. Clin. Psychiatry 2007; 68: 566-571.
23. Murawiec S. Relationships between positive or negative early subjective response to antipsychotics and demographic and clinical variables in the group of patients with schizophrenia. Psychiatr. Pol. 2005; 39: 1185-1198.
24. Pallant J. SPSS Survival Manual: A Step by Step Guide to Data Analysis Using SPSS (2nd edn). Sydney: Allen & Unwin, 2005.
25. Perkins DO. Predictors of noncompliance in patients with schizophrenia. J. Clin. Psychiatry 2002; 63: 1121-1128.
26. Pharaoh F, Mari J, Rathbone J, Wong W. Family intervention for schizophrenia. Cochrane Database Syst. Rev. 2006; 4: Art. no. CD000088.
27. Pollock K, Grime J. Meeting the Treatment Information Needs of Users of Specialist Mental Health Services. A Study of Users' Experience of Information Provision within a Complex System of Care: Final Report of the Concordance Research Fellowship. Keele, UK: Department of Medicines Management, Keele University, 2004.
28. Pyne JM, McSweeney J, Kane HS, Harvey S, Bragg L, Fischer E. Agreement between patients with schizophrenia and providers on factors of antipsychotic medication adherence. Psychiatr. Serv. 2006; 57: 1170-1178.
29. Razali MS, Yahya H. Compliance with treatment in schizophrenia: A drug intervention program in a developing program. Acta Psychiatr. Scand. 1995; 91: 331-335.
30. Robinson DG, Woerner MG, Alvir JM et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry 1999; 56: 241-247.
31. Sajatovic M, Bauer MS, Kilbourne AM, Vertrees JE, Williford W. Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatr. Serv. 2006; 57: 56-62.
32. Sellwood W, Tarrier N, Quinn J, Barrowclough C. The family and compliance in schizophrenia: The influence of clinical variables, relatives' knowledge and expressed emotion. Psychol. Med. 2003; 33: 91-96.
33. Servellen GV, Lombardi E. Supportive relationships and medication adherence in HIV-infected, low-income Latinos. West. J. Nurs. Res. 2005; 27: 1023-1039.
34. Voils CI, Steffens DC, Flint EP, Bosworth HB. Social support and locus of control as predictors of adherence to antidepressant medication in an elderly population. Am. J. Geriatr. Psychiatry 2005; 13: 157-165.
35. Weiden PJ, Dixon L, Frances A, Appelbaum P, Haas G, Rapkin B. Neuroleptic noncompliance in schizophrenia. In: Tamminga CA, Schulz SC (eds). Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology. New York: Raven Press, 1991; 285-296.
36. Weiss KA, Smith TE, Hull JW, Piper AC, Huppert JD. Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders. Schizophr. Bull. 2002; 28: 341-349.
37. World Health Organization. Adherence to Long-term Therapies: Evidence for Action. Geneva: World Health Organization, 2003.
38. Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am. J. Psychiatry 2002; 159: 1653-1664.